Provided by Tiger Fintech (Singapore) Pte. Ltd.

Autolus Therapeutics PLC

1.34
-0.0150-1.11%
Volume:602.91K
Turnover:803.17K
Market Cap:355.28M
PE:-1.54
High:1.37
Open:1.36
Low:1.30
Close:1.35
Loading ...

Autolus Therapeutics presents clinical data updates at Tandem Meetings

TIPRANKS
·
17 Jan

Synairgen Strengthens Board with Appointment of Martin Murphy

TIPRANKS
·
16 Jan

European Equities Traded in the US as American Depositary Receipts Start Week Lower in Monday Trading

MT Newswires Live
·
14 Jan

Press Release: Autolus Therapeutics Provides Business Updates and 2025 Overview

Dow Jones
·
13 Jan

Autolus Therapeutics Provides Business Updates and 2025 Overview

GlobeNewswire
·
13 Jan

European Equities Traded in US as American Depositary Receipts Surge on Monday

MT Newswires Live
·
07 Jan

European Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading

MT Newswires Live
·
03 Jan

Why Autolus Therapeutics (AUTL) Is One of the Best Biotech Penny Stocks to Invest in Now?

Insider Monkey
·
31 Dec 2024

European Equities Traded in US as American Depositary Receipts Tread Water Friday, Up 3% for Week

MT Newswires Live
·
28 Dec 2024

European Equities Traded in the US as American Depositary Edge Higher in Thursday Trading

MT Newswires Live
·
27 Dec 2024

European Equities Traded in the US as American Depositary Receipts Start Week Down Slightly in Monday Trading

MT Newswires Live
·
24 Dec 2024

European Equities Traded in the US as American Depositary Receipts Tumble in Friday Trading; Down 4.6% for Week

MT Newswires Live
·
21 Dec 2024

European Equities Traded in the US as American Depositary Rise in Wednesday Trading

MT Newswires Live
·
19 Dec 2024

European Equities Traded in the US as American Depositary Receipts Kick Off Week Higher in Monday Trading

MT Newswires Live
·
17 Dec 2024

European Equities Traded in the US as American Depositary Edge Higher in Wednesday Trading

MT Newswires Live
·
12 Dec 2024

Autolus Therapeutics presents clinical data updates at ASH meeting

TIPRANKS
·
10 Dec 2024

Autolus Therapeutics Price Target Maintained With a $10.00/Share by Needham

Dow Jones
·
09 Dec 2024

Autolus Therapeutics: Undervalued Potential in ALL Treatment with Obe-cel

TIPRANKS
·
09 Dec 2024

Autolus Therapeutics plc (AUTL): A Bull Case Theory

Insider Monkey
·
06 Dec 2024

Positive Outlook for Autolus Therapeutics Driven by Regulatory Approval and Competitive Positioning in CAR-T Therapy

TIPRANKS
·
06 Dec 2024